Education
About Us
Working with TipRanks
Follow Us
Stephen Mayo Insider Profile
11 Followers
Stephen Mayo, Director at Merck & Company, holds 100.00 shares in Merck & Company (Ticker: MRK), holds 6.62K shares in Sarepta Therapeutics (Ticker: SRPT), holds 25.33K shares in Allogene Therapeutics (Ticker: ALLO). Most recently, Stephen Mayo ― shares of Merck & Company on ― for an estimated value of ―.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+27.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stephen Mayo holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 09, 2023 - Aug 09, 2024
Return:+46.50%
The most profitable trade made by Stephen Mayo
Stephen Mayo's Trading History
Merck & Company
―
Director
―
$9.46K
Sarepta Therapeutics
Mar 06, 2024
Director
Informative Sell
385.48K
$682.16K
Allogene Therapeutics
Aug 09, 2023
Director
Informative Sell
42.80K
$55.22K
List of latest transactions for each holding click on a transaction to see Stephen Mayo's performance on stock
You May Also Like
Stephen Mayo insider profile FAQ
What is the percentage of profitable transactions made by Stephen Mayo?
The percentage of profitable transactions made by Stephen Mayo is 100%.
What is the average return per transaction made by Stephen Mayo?
The average return per transaction made by Stephen Mayo is 27.50%.
What stocks does Stephen Mayo hold?
Stephen Mayo holds: MRK, SRPT, ALLO stocks.
What was Stephen Mayo’s latest transaction?
Stephen Mayo latest transaction was an Uninformative Buy of ―.
What was Stephen Mayo's most profitable transaction?
Stephen Mayo’s most profitable transaction was an Informative Sell of ALLO stock on August 9, 2023. The return on the trade was 46.50%.
What is Stephen Mayo's role in Merck & Company?
Stephen Mayo's role in Merck & Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.